Stem cells reverse symptoms of multiple sclerosis, study finds

01/29/2009 | Yahoo!

A U.S. study involving 21 people with relapsing-remitting multiple sclerosis -- an earlier phase in the disease -- reported that about 81% showed improvement after their immune systems were reset through an injection of stem cells derived from their own bone marrow. Called autologous nonmyeloablative hematopoietic stem cell transplantation, the treatment is less toxic than the chemotherapy treatment used in cancer patients because it targets only the immune system component of bone marrow, one of the scientists said.

View Full Article in:

Yahoo!

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Catheter Engineer Manager
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA
Director, Office of Device Evaluation
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Director, Office of Compliance
FDA, Center for Devices and Radiological Health
Silver Spring, MD